Evidence map›Paper›PMID 31418142›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

Protein compounds of Bacillus subtilis with in vitro antifungal activity against Pseudocercospora fijiensis (Morelet).

Mileidy Cruz-Martín, Eilyn Mena, Mayra Acosta-Suárez, Tatiana Pichardo, Eloisa Rodriguez, Yelenys Alvarado-Capó

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mileidy Cruz-MartínInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba. mileidy@ibp.co.cu.ORCID http://orcid.org/0000-0003-3825-499X
Eilyn MenaInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba.
Mayra Acosta-SuárezInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba.
Tatiana PichardoInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba.
Eloisa RodriguezInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba.
Yelenys Alvarado-CapóInstituto de Biotecnología de las Plantas, Universidad Central Marta Abreu de Las Villas, Carretera a Camajuaní km 5.5., CP 54830, Santa Clara, Villa Clara, Cuba.

Funding

DAAD scholarship from the Food Security Center from the University of Hohenheim
6 · The paper itself

Abstract

The metabolites of Bacillus subtilis CCIBP-M27 were evaluated as an antagonist of Pseudocercospora fijiensis. The culture filtrate did not inhibit ascospore germination but significantly reduced conidial germination and mycelial growth. Through microscopic analysis, deformations were observed as vacuolization and swelling in P. fijiensis mycelia when exposed to culture filtrate during 48 h. A similar response was induced by peptide-type compounds found on Bacillus subtilis CCIBP-M27 culture filtrate. The results obtained suggest that the in vitro antifungal effect of the strain CCIBP-M27 against P. fijiensis is related to the action of diffused metabolites such as proteins or peptide substances.

Indexed as

Antifungal AgentsAscomycotaBacillus subtilisBacterial ProteinsBiological Control AgentsIn Vitro TechniquesMyceliumPlant DiseasesSpores, FungalAntifungal AgentsBacterial ProteinsBiological Control AgentsBiocontrolBlack SigatokaMetabolitesProteins

Identifiers

PMID31418142
PMCPMC7058733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.